《新股消息》传零氪科技拟年内上市筹5亿美元 阿里健康(00241.HK)参投
据《彭博通讯社》引述消息人士指,内地医疗数据解决方案及肿瘤大数据平台零氪科技(LinkDoc)正计划最快今年内上市,集资约5亿美元,潜在上市地点包括香港,目前正与美银、中金及摩根士丹利讨论IPO相关筹备工作。
零氪科技成立於2014年,资料显示公司主要从事人工智能与医疗大数据业务,为政府部门、各级医疗机构、国内外医疗器械厂商、药企等提供解决方案,以及人工智能辅助决策系统、患者全流程管理等一体化服务,投资者包括阿里健康(00241.HK)、汇桥资本及CBC Capital等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.